New drug initiative aims to support development and review of RMPs in EU
This article was originally published in SRA
Executive Summary
An initiative that is being supported by the EU Heads of Medicines Agencies will soon be in place to help pharmaceutical companies in preparing risk management plans (RMPs) and assist EU member states in assessing these documents.